03:10 PM EST, 11/05/2025 (MT Newswires) -- Bausch + Lomb ( BLCO ) is hosting an investor day on Nov. 13 in New York City. Needham, which is maintaining a Hold rating on the stock, is expecting management to focus on BLCO's pipeline and to provide financial targets for 2028.

"While we expect pipeline commentary to be positive, we don't see any catalyst to result in meaningful near-term multiple expansion, especially with limited visibility to a full separation from parent Bausch Health (BHC)," analyst David Saxon writes.

Price: 22.25, Change: +1.11, Percent Change: +5.25